Innovative Eyewear officer to sell 3,912 shares

Available on EDGAR 09/21/2026 - 12:27 PM EDT Accepted by SEC EDGAR 09/21/2026 - 12:26 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Innovative Eyewear Inc (LUCY) received a Rule 144 notice indicating that officer Joaquin Abondano, through Raymond James & Associates, Inc., plans to sell 3,912 shares of common stock, with an aggregate market value of $3,376.14, on or about September 18, 2026. The notice states that 8,600,000 shares of this class were outstanding. It also lists an RSU grant of 14,800 common shares dated August 19, 2026, and discloses that Abondano sold 5,020 shares over the past three months for proceeds of $3,288.00.

Key Figures

Shares to be sold under Rule 144: 3,912 shares Aggregate market value of planned sale: $3,376.14 Shares outstanding: 8,600,000 shares +4 more

7 metrics

Shares to be sold under Rule 144 3,912 shares Planned sale of Innovative Eyewear common stock by officer Joaquin Abondano

Aggregate market value of planned sale $3,376.14 Value of the 3,912 shares of Innovative Eyewear common stock to be sold

Shares outstanding 8,600,000 shares Outstanding Innovative Eyewear common shares referenced in the Rule 144 notice

Approximate date of sale September 18, 2026 Planned date for the Rule 144 sale of 3,912 shares

RSU grant shares 14,800 shares Common shares underlying an RSU grant dated August 19, 2026

Shares sold in past 3 months 5,020 shares Sales of Innovative Eyewear common stock by Joaquin Abondano during past three months

Proceeds from past 3 months sales $3,288.00 Aggregate proceeds from sale of 5,020 shares

Key Terms

Rule 144, RSU Grant, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSU Grant financial

"Common | 08/19/2026 | RSU Grant | Issuer |"

aggregate market value financial

"Common | Raymond James & Associates, Inc. ... | 3912 | 3376.14 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Innovative Eyewear Inc (LUCY)?

It discloses that officer Joaquin Abondano plans to sell 3,912 shares of Innovative Eyewear common stock under Rule 144 through Raymond James & Associates, Inc., with an aggregate market value of $3,376.14 and an approximate sale date of September 18, 2026.

How many LUCY shares are planned to be sold under this Rule 144 notice?

The notice states that 3,912 shares of Innovative Eyewear Inc common stock are planned to be sold under Rule 144, with an aggregate market value of $3,376.14 and an approximate sale date of September 18, 2026.

How many Innovative Eyewear (LUCY) shares are outstanding according to this filing?

The filing reports that there are 8,600,000 shares of Innovative Eyewear Inc common stock outstanding, as context for the planned Rule 144 sale of 3,912 shares by officer Joaquin Abondano.

What equity award to Joaquin Abondano is mentioned for LUCY in this document?

The document lists an RSU Grant of 14,800 common shares of Innovative Eyewear Inc to Joaquin Abondano, with a stated acquisition date of August 19, 2026 and cash noted as the nature of payment on that same date.

What LUCY share sales by Joaquin Abondano occurred in the past 3 months?

The filing discloses that Joaquin Abondano sold 5,020 shares of Innovative Eyewear Inc common stock during the past three months, for aggregate proceeds of $3,288.00.

Who is the broker for the planned Rule 144 sale of LUCY shares?

The broker listed for the planned Rule 144 sale is Raymond James & Associates, Inc., located at 880 Carillon Parkway, St. Petersburg, Florida, handling the proposed sale of 3,912 shares of Innovative Eyewear Inc common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002008020
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Innovative Eyewear Inc
SEC File Number	001-41392
Address of Issuer	11900 BISCAYNE BLVD STE 630 MIAMI FLORIDA 33181
Phone	786-910-1898
Name of Person for Whose Account the Securities are To Be Sold	Abondano Joaquin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates, Inc. 880 Carillon Parkway St. Petersburg, FL 33716	3912	3376.14	8600000	09/18/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	RSU Grant	Issuer			14800	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Joaquin Abondano 2 Grove isle Dr. B308 Miami FL 33133	Common	08/19/2026	5020	3288.00

144: Remarks and Signature

Remarks
Date of Notice	09/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Joaquin Abondano
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)